Wall Street analyst price targets, ratings consensus & upside potential · Updated May 1, 2026
Last 12 months price action with 12-month analyst target path
As of May 8, 2026, ArcBest Corporation (ARCB) has a Wall Street consensus price target of $117.14, based on estimates from 24 covering analysts. With the stock currently trading at $121.78, this represents a potential downside of -3.8%. The company has a market capitalization of $2.72B.
Analyst price targets range from a low of $85.00 to a high of $150.00, representing a 55% spread in expectations. The median target of $117.00 aligns closely with the consensus average. The wide target spread reflects significant disagreement on fair value.
The current analyst consensus rating is Buy, with 12 analysts rating the stock as a Buy or Strong Buy,11 rating it Hold, and 1 rating it Sell or Strong Sell. The positive sentiment balance indicates moderate optimism about the stock prospects.
From a valuation perspective, ARCB trades at a trailing P/E of 46.5x and forward P/E of 23.6x. Analysts expect EPS to grow +106.0% over the next year.
Our proprietary valuation model, which blends historical multiples with forward estimates, suggests a base-case price target of $220.05, with bear and bull scenarios of $77.59 and $703.67 respectively. Model confidence stands at 51/100, reflecting moderate uncertainty in projections.
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorDCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationSide-by-side business, growth, and profitability comparison vs Spire Global, Inc..
Start ComparisonQuick answers to the most common questions about buying ARCB stock.
Wall Street's consensus price target for ARCB is $117.14, -3.8% from its current price of $121.78. The below-market target from 24 analysts suggests limited near-term appreciation.
ARCB has a consensus rating of "Buy" based on 24 Wall Street analysts. The rating breakdown is mixed, with 11 Hold ratings making up the largest segment. The consensus 12-month price target of $117.14 implies -3.8% downside from current levels.
ARCB trades at a forward P/E of 23.6131x, representing a moderate valuation. With analysts targeting $117.14 (-3.8% implied move), the stock appears close to fair value.
The most bullish Wall Street analyst has a price target of $150 for ARCB, while the most conservative target is $85. The consensus of $117.14 represents the median expectation. Our quantitative valuation model projects a bull case target of $704 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.
ARCB is well covered by analysts, with 24 analysts providing price targets and ratings. Of these, 1 have Strong Buy ratings, 11 have Buy ratings, 11 recommend Hold, and 1 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month ARCB stock forecast based on 24 Wall Street analysts shows a consensus price target of $117.14, with estimates ranging from $85 (bear case) to $150 (bull case). The median consensus rating is "Buy". Our proprietary valuation model produces a base case fair value of $220, with bear/bull scenarios of $78/$704.
Our quantitative valuation model calculates ARCB's fair value at $220 (base case), with a bear case of $78 and bull case of $704. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 51/100.
ARCB trades at a forward P/E ratio of 23.6x based on next-twelve-months earnings estimates compared to a trailing P/E of 46.5x. The lower forward P/E indicates analysts expect earnings growth. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
Analysts are cautious on ARCB, with 1 Sell ratings and a price target of $117.14 (-3.8% from current price). The "Buy" consensus suggests careful evaluation before buying. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
ARCB analyst price targets range from $85 to $150, a 55% wide spread indicating significant analyst disagreement. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $117.14 consensus represents the middle ground. Our model's $78-$704 range provides an independent fundamental perspective.